Table 3 Tumour response to cancer treatment

From: Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

Tumour response

Epoetin alfa ( n= 114)

Best standard treatment ( n= 59)

Complete, n (%)

55 (48)

33 (56)

Partial, n (%)

25 (22)

19 (32)

None, n (%)

7 (6)

5 (9)

Progressive disease, n (%)

13 (11)

1 (2)

Unknown, n (%)

14 (12)

1 (2)

Back to article page